Metronidazole (MTZ) is the most preferred choice of drugs for intestinal amoebiasis.1) This drug is to be delivered to the colon for its effective action against Entamoebe histolytica wherein the trophozoites reside in the lumen of the caecum and large intestine and also adhere to the colonic mucus and epithelial layers.2) But the pharmacokinetic profile of metronidazole indicates that the drug is completely and promptly absorbed after oral administration and plasma concentration of about 10 mg/ml is reached approximately 1 h after a single 500 mg dose.3) The administration of this drug in conventional tablet dosage form provides minimal amount of metronidazole for local action in the colon, still resulting in the relief of amoebiasis, but with unwanted systemic effects. Thus there is strong clinical need and market potential for a delivery system that will deliver maximum amount of MTZ to the colon in controlled manner.Colon targeted delivery systems are well recognized and documented to deliver most of the drugs to colon. In the past, various primary approaches for colon targeted delivery, such as, prodrugs approach, 4) pH, 5) and time 6) and pressure dependent systems, 7) have achieved limited success. The majority of these systems, developed during the past decade, were based on pH and time dependent mechanisms with limited in-vivo evaluation.8) Minor variation in pH between the small intestine and the colon makes the pH-dependent systems less specific, in terms of targeted release in the colon. Time-dependent systems predominantly depend on the transit time of the delivery system in the gastrointestinal tract (GIT). A major limitation with these systems is that in vivo variation of the small intestinal transit time may lead to release of the drugs in the small intestine or terminal part of the colon.
9,10)The patho-physiological state of an individual will have a significant impact on the performance of these time-dependent systems. Patients with irritable bowel syndrome and ulcerative colitis exhibited accelerated transit through different regions of the colon.
11,12)The best alternative approach for colon specific drug delivery is the use of carriers that are degraded exclusively by colonic bacteria. Most of the carrier based systems provide controlled delivery of drugs in matrix and/or reservoir type systems, which pose problems of bioavailability fluctuation due to pH variations. 13,14) Moreover, the release of drugs from matrix and/or reservoir type systems is affected by hydrodynamic conditions of the body.Osmotic drug delivery system (ODDS) utilizes the principle of osmotic pressure for controlled delivery of drugs.
15)Drug release from these systems is independent of pH and other physiological parameter to a large extent and exhibit significant in vitro-in vivo correlation.16) Drug delivery from ODDS follow zero-order kinetic hence provides better control over in-vivo performance. Various types of osmotic pumps have been reported to target the drug to colon for local or systemic therapy. [17][18][19...